Atlas Trials

IST Neoadjuvant Abraxane in Newly Diagnosed Breast Cancer

Clinical trial NCT01830244 · UNKNOWN

Trial details

NCT number
NCT01830244
Sponsor
Barwon Health
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2013-04-01
Primary completion
2015-09-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.